Evidence map›Paper›PMID 26951199›Full record

ArticleMolecular and cellular biology2016

The Inositol-3-Phosphate Synthase Biosynthetic Enzyme Has Distinct Catalytic and Metabolic Roles.

Anna D Frej, Jonathan Clark, Caroline I Le Roy, Sergio Lilla, Peter A Thomason, Grant P Otto, Grant Churchill, Robert H Insall, Sandrine P Claus, Phillip Hawkins and 2 more

Open access · hybridAbstract read
In one paragraph

Article in Molecular and cellular biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 23 citations in OpenAlex.

  1. Adhesion ofFrontiers in cell and developmental biology · 2022
    Review
  2. Myoinositol in Autoimmune Thyroiditis.Frontiers in endocrinology · 2022
    Review
  3. Article
  4. Aberrant Autophagy Impacts Growth and Multicellular Development in aFrontiers in cell and developmental biology · 2021
    Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 1 country.

Anna D FrejCentre for Biomedical Sciences, School of Biological Sciences, Royal Holloway University of London, Egham, Surrey, United Kingdom.
Jonathan ClarkThe Babraham Institute, Cambridge, Cambridgeshire, United Kingdom.
Caroline I Le RoyDepartment of Food and Nutritional Sciences, The University of Reading, Reading, Berkshire, United Kingdom.
Sergio LillaCancer Research UK Beatson Institute, Bearsden, Glasgow, United Kingdom.
Peter A ThomasonCancer Research UK Beatson Institute, Bearsden, Glasgow, United Kingdom.
Grant P OttoCentre for Biomedical Sciences, School of Biological Sciences, Royal Holloway University of London, Egham, Surrey, United Kingdom.
Grant ChurchillDepartment of Pharmacology, University of Oxford, Oxford, Oxfordshire, United Kingdom.
Robert H InsallCancer Research UK Beatson Institute, Bearsden, Glasgow, United Kingdom.
Sandrine P ClausDepartment of Food and Nutritional Sciences, The University of Reading, Reading, Berkshire, United Kingdom.
Phillip HawkinsThe Babraham Institute, Cambridge, Cambridgeshire, United Kingdom.
Len StephensThe Babraham Institute, Cambridge, Cambridgeshire, United Kingdom.
Robin S B WilliamsCentre for Biomedical Sciences, School of Biological Sciences, Royal Holloway University of London, Egham, Surrey, United Kingdom robin.williams@rhul.ac.uk.
Babraham Institute · GBCancer Research UK Scotland Institute · GBRoyal Holloway University of London · GBUniversity of Reading · GBUniversity of Oxford · GB

Funding

Cancer Research UK 15672
6 · The paper itself

Abstract

Inositol levels, maintained by the biosynthetic enzyme inositol-3-phosphate synthase (Ino1), are altered in a range of disorders, including bipolar disorder and Alzheimer's disease. To date, most inositol studies have focused on the molecular and cellular effects of inositol depletion without considering Ino1 levels. Here we employ a simple eukaryote, Dictyostelium discoideum, to demonstrate distinct effects of loss of Ino1 and inositol depletion. We show that loss of Ino1 results in an inositol auxotrophy that can be rescued only partially by exogenous inositol. Removal of inositol supplementation from the ino1(-) mutant resulted in a rapid 56% reduction in inositol levels, triggering the induction of autophagy, reduced cytokinesis, and substrate adhesion. Inositol depletion also caused a dramatic generalized decrease in phosphoinositide levels that was rescued by inositol supplementation. However, loss of Ino1 triggered broad metabolic changes consistent with the induction of a catabolic state that was not rescued by inositol supplementation. These data suggest a metabolic role for Ino1 that is independent of inositol biosynthesis. To characterize this role, an Ino1 binding partner containing SEL1L1 domains (Q54IX5) and having homology to mammalian macromolecular complex adaptor proteins was identified. Our findings therefore identify a new role for Ino1, independent of inositol biosynthesis, with broad effects on cell metabolism.

Indexed as

AutophagyCytokinesisDictyosteliumInositolIntramolecular LyasesMetabolismMutationProtozoan ProteinsD-myo-inositol-3-phosphate synthaseInositolIntramolecular LyasesProtozoan Proteins

Identifiers

PMID26951199
PMCPMC4859692
OpenAlexW2296581182

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.